Petros C Karakousis Selected Research

Petros C Karakousis Research Topics

Disease

59	Tuberculosis (Tuberculoses) 11/2021 - 09/2004
52	Infections 08/2022 - 09/2004
11	Granuloma 01/2020 - 09/2004
9	Starvation 01/2021 - 10/2009
8	Hypoxia (Hypoxemia) 01/2018 - 02/2008
6	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018 - 01/2012
5	COVID-19 08/2022 - 01/2020
4	Inflammation (Inflammations) 01/2022 - 09/2009
4	Neoplasms (Cancer) 10/2021 - 05/2015
4	Latent Tuberculosis 05/2015 - 08/2007
3	Communicable Diseases (Infectious Diseases) 12/2021 - 07/2015
3	Body Weight (Weight, Body) 07/2014 - 07/2012
2	Necrosis 01/2022 - 01/2016
2	Bacterial Infections (Bacterial Infection) 01/2021 - 09/2014
2	Uveitis 09/2009 - 10/2008
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2007 - 09/2004
1	Virus Diseases (Viral Diseases) 08/2022
1	Pulmonary Tuberculosis 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Stroke (Strokes) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Melanoma (Melanoma, Malignant) 04/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020

Drug/Important Bio-Agent (IBA)

22	Pharmaceutical PreparationsIBA 11/2021 - 09/2004
21	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 09/2004
17	Rifampin (Rifampicin)FDA LinkGeneric 01/2018 - 09/2004
14	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 04/2011
11	AerosolsIBA 11/2016 - 06/2007
9	Pyrazinamide FDA LinkGeneric 03/2016 - 09/2009
6	VaccinesIBA 12/2021 - 01/2013
5	CholesterolIBA 08/2022 - 12/2020
5	Thioridazine (Mellaril)FDA LinkGeneric 12/2014 - 05/2011
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 09/2014
4	Phosphates (Orthophosphate)IBA 01/2018 - 10/2009
4	CytokinesIBA 07/2014 - 11/2010
3	Triglycerides (Triacylglycerol)IBA 08/2022 - 01/2021
3	oxidized low density lipoproteinIBA 08/2022 - 01/2021
3	LipidsIBA 08/2022 - 01/2021
3	Virulence Factors (Pathogenicity Factors)IBA 03/2016 - 09/2011
3	AcidsIBA 03/2015 - 08/2007
3	Interferon-gamma (Interferon, gamma)IBA 09/2014 - 09/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 11/2010
3	RifamycinsIBA 08/2013 - 07/2012
3	rifapentine (Priftin)FDA Link 03/2013 - 07/2012
2	Immunoglobulin A (IgA)IBA 04/2021 - 01/2021
2	Immunoglobulin M (IgM)IBA 04/2021 - 01/2021
2	Protein SIBA 04/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 04/2021 - 01/2021
2	Guanosine PentaphosphateIBA 01/2021 - 11/2010
2	C-Reactive ProteinIBA 01/2021 - 01/2020
2	PolyphosphatesIBA 01/2021 - 10/2009
2	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2015
2	Simvastatin (Zocor)FDA LinkGeneric 12/2020 - 09/2014
2	DNA VaccinesIBA 04/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2011
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 06/2013 - 05/2011
2	ChemokinesIBA 05/2013 - 07/2012
2	pimonidazoleIBA 01/2011 - 07/2008
1	HDL CholesterolIBA 08/2022
1	LDL CholesterolIBA 08/2022
1	Viral RNAIBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2021
1	AlbuminsIBA 10/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021
1	Argonaute ProteinsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	KynurenineIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Transfer RNA (tRNA)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Mevalonic Acid (Mevalonate)IBA 12/2020
1	AntigensIBA 04/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	EnzymesIBA 01/2019
1	BCG Vaccine FDA Link 01/2018
1	Detergents (Detergent)IBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018

Therapy/Procedure

14	Therapeutics 08/2022 - 07/2008
6	Duration of Therapy 10/2021 - 08/2012
4	Drug Therapy (Chemotherapy) 01/2020 - 09/2004
3	Highly Active Antiretroviral Therapy (HAART) 01/2011 - 09/2004
1	Immunotherapy 10/2021
1	Length of Stay 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 04/2020
1	Critical Care (Surgical Intensive Care) 01/2020